title: Mastocytosis and related disorders.
abstract: Mastocytosis represents a heterogeneous group of disorders characterized by an abnormal accumulation of mast cells in one or more organ systems. Mastocytosis is further divided into different subtypes according to the sites of involvement, laboratory findings, and degree of organ impairment. Cutaneous mastocytosis is diagnosed in the presence of skin involvement and absence of extracutaneous disease, and is most commonly seen in the pediatric population. Systemic mastocytosis, the disease form most commonly seen in adults, is characterized by the presence of multifocal, compact (dense) mast cell aggregates in the bone marrow or other extracutaneous organs. The mast cells may display atypical, often spindle-shape morphology and/or aberrant CD2 and/or CD25 expression. Elevation of serum tryptase and/or presence of KIT D816V mutation are other common findings. Systemic mastocytosis is further divided into different subtypes based on a combination of clinical features and laboratory findings. Recent studies have indicated that CD30 is frequently expressed in aggressive systemic mastocytosis and mast cell leukemia but infrequently in indolent systemic mastocytosis, and may be a useful marker for distinguishing these subtypes of systemic mastocytosis from one another. A group of related myeloid disorders, collectively termed myelomastocytic overlap syndromes, may pose diagnostic difficulty because of their significant clinical and pathologic overlap with systemic mastocytosis, and these will also be discussed in this review.
authors.affiliation: Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. achiu1@partners.org
authors.forename: April
authors.initials: A
authors.lastname: Chiu
authors.forename: Attilio
authors.initials: A
authors.lastname: Orazi
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology; D018801:CD2 Antigens / Q000378:metabolism; D003937:Diagnosis, Differential; D006801:Humans; D053645:Interleukin-2 Receptor alpha Subunit / Q000378:metabolism; D017730:Ki-1 Antigen / Q000378:metabolism; D008407:Mast Cells / Q000378:metabolism / Q000473:pathology*; D034701:Mastocytosis, Cutaneous / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism; D034721:Mastocytosis, Systemic / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D054437:Myelodysplastic-Myeloproliferative Diseases / Q000175:diagnosis; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics; D053802:Tryptases / Q000097:blood
chemical_list: D014408:Biomarkers, Tumor; D018801:CD2 Antigens; C508017:IL2RA protein, human; D053645:Interleukin-2 Receptor alpha Subunit; D017730:Ki-1 Antigen; D019009:Proto-Oncogene Proteins c-kit; D053802:Tryptases